Decibel Therapeutics, Inc.·4

Sep 17, 9:48 PM ET

Reid Laurence 4

4 · Decibel Therapeutics, Inc. · Filed Sep 17, 2021

Insider Transaction Report

Form 4
Period: 2021-09-15
Reid Laurence
DirectorSee Remarks
Transactions
  • Purchase

    Common Stock

    2021-09-15$7.64/sh+10,000$76,40025,849 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.587 to $7.65, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION